News
ARK’s ARKK ETF also added 165,024 shares of CRISPR Therapeutics AG (NASDAQ:CRSP) to its portfolio, valued at $9,706,711. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback